Statistiche web
April 25, 2024

patients

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform Auto Draft
3 min read

Tevogen Bio Announces Positive Proof-of-Concept Clinical Trial Results of Its Off-The-Shelf, Allogeneic Cytotoxic CD8+ T Cell Therapy for Treatment of Acute High-Risk COVID Patients, First Clinical Product of Company’s Precision Cell Therapy Platform

AETOSWire January 25, 2023
WARREN, N.J. — Tevogen Bio today announced positive topline results from its Proof-of-Concept (POC) clinical trial designed to evaluate the safety...
Read More
Accutar Biotechnology Announces First Patient Dosed with AC0176 in Phase 1 Study in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Accutar Biotechnology Announces First Patient Dosed with AC0176 in Phase 1 Study in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)
2 min read

Accutar Biotechnology Announces First Patient Dosed with AC0176 in Phase 1 Study in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

AETOSWire April 1, 2022
BROOKLYN, N.Y.–(BUSINESS WIRE/AETOSWire)– Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug...
Read More

You may have missed

Home Centre Launches “Restore, Rebuild, Renew” Campaign to Support The UAE Community in Wake of Rainfall Home Centre Launches “Restore, Rebuild, Renew” Campaign to Support The UAE Community in Wake of Rainfall
2 min read

Home Centre Launches “Restore, Rebuild, Renew” Campaign to Support The UAE Community in Wake of Rainfall

April 25, 2024
The Spotty Ghaidaan The Spotty Ghaidaan
4 min read

The Spotty Ghaidaan

April 25, 2024
Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated
3 min read

Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance reiterated

April 25, 2024
Anxinsec, an Abu Dhabi-based cybersecurity company, and the Cyber Security Council signed an MOU at GISEC2024 to boost cybersecurity collaboration Anxinsec, an Abu Dhabi-based cybersecurity company, and the Cyber Security Council signed an MOU at GISEC2024 to boost cybersecurity collaboration
2 min read

Anxinsec, an Abu Dhabi-based cybersecurity company, and the Cyber Security Council signed an MOU at GISEC2024 to boost cybersecurity collaboration

April 25, 2024
free web counter